News | June 25, 2024
Venus Remedies clinches WHO-backed PAHO tender
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Combined entity is better positioned to compete in increasingly competitive generics industry
PEKK is a high-performance polymer family used in aerospace and other demanding markets
_256_384.jpg)
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Renews GMP certifications for India and Malaysia sites
The Issue opened on June 18, 2024 and closed on June 21, 2024
The company will now explore a buyer for its manufacturing site and exit in due course
Subscribe To Our Newsletter & Stay Updated
